Table 5.
Respective distributions of the highest organisational hierarchy levels for the deficiencies and actions associated with the cases
Cohort 1 | Cohort 2 | Cohort 3 | ||
Organisational level, deficiencies | Micro | 121 (90) | 157 (65) | 179 (73) |
Meso | 13 (10) | 83 (35)* | 67 (27)* | |
Macro | 0 (0) | 0 (0) | 0 (0) | |
Organisational level, actions | Micro | 115 (85) | 225 (65) | 206 (75) |
Meso | 20 (15) | 120 (35)* | 70 (25)* | |
Macro | 0 (0) | 1 (0) | 0 (0) |
Only the highest level for each case is noted. The data in the table comprise numbers and percentages, n (%). Cohort 1: cases reported in 2006–2007, cohort 2: cases reported in 2015 and cohort 3: cases reported in 2017–2019.
*Significantly larger proportion of cases with deficiencies or actions at the mesosystem level when compared with cohort 1, p<0.005.